Paper Details

  1. Home
  2. Paper Details

Overview of Systemic Therapy Augmenting Management of High-risk Localized Prostate Cancer.

Author: FengFelix Y, FizaziKarim, VicierCécile

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

A common treatment for high-risk prostate cancer that hasn't spread is a combination of radiation therapy and long-term hormone therapy. Studies are underway to investigate the use of chemotherapy or newer hormone therapies in combination with localized treatments for these specific patients.
Paper Details　
Original Abstract of the Article :
One of the standard management options for high-risk localized prostate cancer is radiotherapy combined with long-term androgen deprivation therap...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.euf.2019.01.015

データ提供：米国国立医学図書館（NLM）

High-Risk Prostate Cancer: A Desert of Uncertainty

This research delves into the challenging landscape of high-risk localized prostate cancer, a formidable foe. Imagine a vast desert, where the sands of time can shift unexpectedly, bringing with them both hope and uncertainty. The study explores the current management options for this complex disease, emphasizing the importance of combining radiotherapy with long-term androgen deprivation therapy. It's a journey through the world of cancer treatment, seeking to find the most effective ways to combat this relentless disease.

Navigating the Desert of Treatment: A Journey of Hope

The research highlights the ongoing clinical trials investigating the potential benefits of combining chemotherapy or next-generation hormone therapies with local treatments for high-risk localized prostate cancer. It’s like searching for a new oasis in a desert, seeking a source of relief and potentially a cure. These trials represent a beacon of hope for patients facing this challenging diagnosis, offering the promise of more effective and personalized treatments.

Harnessing the Power of Collaboration: A Journey of Discovery

This research emphasizes the importance of collaboration and innovation in cancer research. It’s like a camel caravan traversing a vast desert, where the success of the journey depends on teamwork and a shared commitment to reaching the destination. By working together, we can unlock new insights into the mechanisms of cancer and develop more effective treatment strategies, offering hope for patients and a brighter future for cancer care.

Dr. Camel's Conclusion

This research explores the complexities of high-risk localized prostate cancer, a formidable foe. It's like navigating a vast desert, where the sands of time can shift unexpectedly, bringing with them both hope and uncertainty. The study highlights the importance of ongoing research and collaboration in developing more effective treatment strategies, offering hope for patients and a brighter future for cancer care.

Date :
  1. Date Completed 2019-12-13
  2. Date Revised 2019-12-17
Further Info :

Pubmed ID

30745118

DOI: Digital Object Identifier

10.1016/j.euf.2019.01.015

Related Literature

Article Analysis
・Effective treatment of prostate cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.